Zobrazeno 1 - 10
of 232
pro vyhledávání: '"Mineral bone disease"'
Publikováno v:
Romanian Journal of Internal Medicine, Vol 62, Iss 1, Pp 52-60 (2024)
Chronic kidney disease (CKD) has always been a complicated global challenge, ranking as the 12th leading cause of death worldwide. Hemodialysis, being one of the most opted renal replacement therapies (RRTs) for patients with end-stage renal disease
Externí odkaz:
https://doaj.org/article/cb5aa560515a44ddbc827bc7aa03f750
Autor:
Lara C. Verschuur, Anouschka G. Liefting, Bastiaan van Dam, Erik L. Penne, Fenneke C. Frerichs
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 13, Iss 1, Pp 184-190 (2023)
In patients treated with peritoneal dialysis (PD), lowering the calcium level in PD fluids results in lower serum calcium levels and higher parathyroid hormone (PTH) levels. It is hypothesized that this effect is attenuated when patients are using ic
Externí odkaz:
https://doaj.org/article/0876bca63710471194b0a9123b91a835
Autor:
Xenophon Kassianides, Sunil Bhandari
Publikováno v:
Kidney & Blood Pressure Research, Vol 48, Iss 1, Pp 151-164 (2023)
Modern intravenous iron compounds (e.g., ferric carboxymaltose [FCM] and ferric derisomaltose [FDI]) are utilized in the treatment of iron deficiency anemia in non-dialysis-dependent chronic kidney disease (ND-CKD). Product-specific alterations in th
Externí odkaz:
https://doaj.org/article/9d1770c5ba844b88ad1625c0e53e05aa
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 3, p 1859 (2024)
Kidney transplantation is the preferred gold standard modality of treatment for kidney failure. Bone disease after kidney transplantation is highly prevalent in patients living with a kidney transplant and is associated with high rates of hip fractur
Externí odkaz:
https://doaj.org/article/1255b2f36d144c0cb725dd8c953c777a
Autor:
Ashwini Dondapati, Priyanka Govindhan, Priya Subashchandrabose, A B Govindaraj, Milly Mathew, Georgi Abraham
Publikováno v:
Indian Journal of Transplantation, Vol 17, Iss 2, Pp 174-180 (2023)
Mineral and bone disease in the posttransplantation patient is common and requires thorough evaluation for appropriate management. This includes secondary renal osteodystrophy, rickets, osteomalacia, osteoporosis, and osteonecrosis. Biochemical marke
Externí odkaz:
https://doaj.org/article/2bd08019e27c4f3ba06b3548725eec5f
Autor:
Jinwoo Jung, Haekyung Jeon-Slaughter, Hang Nguyen, Jiten Patel, Kamalanathan K. Sambandam, Shani Shastri, Peter Noel Van Buren
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Hyperphosphatemia occurs frequently in end-stage renal disease patients on hemodialysis and is associated with increased mortality. Hyperphosphatemia contributes to vascular calcification in these patients, but there is emerging e
Externí odkaz:
https://doaj.org/article/2e02c4f93103480e887ea9a39965cbc2
Autor:
Anthony Batte, Philip Kasirye, Reagan Baluku, Sarah Kiguli, Robert Kalyesubula, Chandy C. John, Andrew L. Schwaderer, Erik A. Imel, Andrea L. Conroy
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2023)
BackgroundMineral bone disorders (MBD) are common in sickle cell anemia (SCA). Frequent vaso-occlusive crises (VOC) further impact MBD in children with SCA. We evaluated the prevalence of markers of SCA-related MBD (sMBD) in hospitalized children and
Externí odkaz:
https://doaj.org/article/43d0fa61b789443a999bc2479b135438
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/5e42dfdf108c4c328f31f16bba3a6b9a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.